Sutro Biopharma Inc. (STRO)
Sutro Biopharma Statistics
Share Statistics
Sutro Biopharma has 84.46M shares outstanding. The number of shares has increased by 2.42% in one year.
| 84.46M |
| 2.42% |
| 1.6% |
| 77.86% |
| n/a |
| 55,486 |
| 2.96% |
Short Selling Information
The latest short interest is 6.86M, so 8.12% of the outstanding shares have been sold short.
| 6.86M |
| 8.12% |
| 8.17% |
| 4.39 |
Valuation Ratios
The PE ratio is -0.62 and the forward PE ratio is -0.91. Sutro Biopharma's PEG ratio is -0.01.
| -0.62 |
| -0.91 |
| 2.28 |
| 1 |
| 3.17 |
| -0.73 |
| -0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Sutro Biopharma.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.6, with a Debt / Equity ratio of 0.52.
| 2.6 |
| 2.6 |
| 0.52 |
| -0.13 |
| -0.12 |
| -7.67 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $230,643.12 |
| $-845,579.93 |
| 269 |
| 0.16 |
| n/a |
Taxes
| 2.36M |
| -1.05% |
Stock Price Statistics
The stock price has increased by -77.93% in the last 52 weeks. The beta is 1.71, so Sutro Biopharma's price volatility has been higher than the market average.
| 1.71 |
| -77.93% |
| 0.81 |
| 2.27 |
| 44.53 |
| 1,876,692 |
Income Statement
In the last 12 months, Sutro Biopharma had revenue of 62.04M and earned -227.46M in profits. Earnings per share was -2.96.
| 62.04M |
| 54.83M |
| -238.45M |
| -227.46M |
| -180.45M |
| -194.03M |
| -2.96 |
Balance Sheet
The company has 190.3M in cash and 23.15M in debt, giving a net cash position of 167.15M.
| 190.3M |
| 23.15M |
| 167.15M |
| -786.87M |
| 321.43M |
| 154.36M |
Cash Flow
In the last 12 months, operating cash flow was -191.54M and capital expenditures -3.1M, giving a free cash flow of -194.64M.
| -191.54M |
| -3.1M |
| -194.64M |
| -2.53 |
Margins
Gross margin is 88.37%, with operating and profit margins of -384.34% and -366.62%.
| 88.37% |
| -384.34% |
| -362.81% |
| -366.62% |
| -290.85% |
| -384.34% |
| -313.71% |
Dividends & Yields
STRO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for STRO is $6.5, which is 683.1% higher than the current price. The consensus rating is "Hold".
| $6.5 |
| 683.1% |
| Hold |
| 7 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -4.98 |
| 3 |